DUOC‐01, a Cell Therapy Product Derived from Human Cord Blood, Accelerates Remyelination
Sign Up to like & getrecommendations! Published in 2018 at "STEM CELLS Translational Medicine"
DOI: 10.1002/sctm.12356
Abstract: 4 We developed a cell therapy product, DUOC-01, derived from banked human umbilical cord blood, to treat demyelinating conditions in the central nervous system. Previously, we demonstrated that DUOC-01 increased myelination and decreased gliosis and… read more here.
Keywords: medicine; duoc; remyelination; cell therapy ... See more keywords
Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy
Sign Up to like & getrecommendations! Published in 2017 at "Current Hematologic Malignancy Reports"
DOI: 10.1007/s11899-017-0395-9
Abstract: Based on laboratory and clinical research findings and investments in immunotherapy by many institutions in academia, government-funded laboratories, and industry, there is tremendous and deserved excitement in the field of cell and gene therapy. In… read more here.
Keywords: therapy product; product development; cell therapy; considerations cell ... See more keywords